Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 48.28B | 50.27B | 43.34B | 38.98B | 38.84B | 36.84B |
Gross Profit | 4.93B | 5.11B | 4.65B | 3.48B | 3.86B | 3.34B |
EBITDA | 2.58B | 2.59B | 2.48B | 1.53B | 2.06B | 1.14B |
Net Income | 1.67B | 1.65B | 1.61B | 900.32M | 1.57B | 652.61M |
Balance Sheet | ||||||
Total Assets | 30.52B | 34.14B | 30.59B | 32.40B | 27.48B | 27.44B |
Cash, Cash Equivalents and Short-Term Investments | 9.04B | 9.28B | 6.75B | 10.08B | 7.66B | 7.11B |
Total Debt | 840.00M | 837.00M | 800.00M | 800.00M | 1.60B | 2.40B |
Total Liabilities | 15.08B | 18.20B | 16.14B | 19.52B | 15.38B | 16.78B |
Stockholders Equity | 15.45B | 15.94B | 14.45B | 12.88B | 12.10B | 10.67B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.88B | -2.10B | 3.15B | 1.50B | 2.84B |
Operating Cash Flow | 0.00 | 3.08B | -1.93B | 3.27B | 1.58B | 3.19B |
Investing Cash Flow | 0.00 | -363.77M | -1.35B | 138.13M | -89.51M | -412.24M |
Financing Cash Flow | 0.00 | -211.87M | -227.96M | -984.41M | -943.57M | -946.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥8.78B | 5.27 | 0.25% | 15.97% | 3.62% | ||
80 Outperform | ¥10.46B | 5.50 | 0.28% | 23.15% | 46.68% | ||
75 Outperform | ¥10.11B | 11.88 | 4.76% | 5.27% | -26.42% | ||
72 Outperform | ¥10.22B | 11.09 | 4.49% | 6.79% | 34.45% | ||
70 Outperform | ¥7.90B | 11.00 | 3.97% | 20.94% | 107.44% | ||
63 Neutral | ¥9.32B | 4.26 | 2.48% | 18.22% | 430.92% | ||
58 Neutral | HK$14.20B | 4.67 | -2.78% | 5.88% | 3.78% | -54.63% |